Viewing Study NCT03906357


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2025-12-29 @ 3:54 PM
Study NCT ID: NCT03906357
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-04-19
First Post: 2019-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access of Pemigatinib to Treat a Single Patient With Metastatic Pancreatic Cancer
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module